Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 652

1.

Effect of mycophenolic acid on inosine monophosphate dehydrogenase (IMPDH) activity in liver transplant patients.

Neuberger M, Sommerer C, Böhnisch S, Metzendorf N, Mehrabi A, Stremmel W, Gotthardt D, Zeier M, Weiss KH, Rupp C.

Clin Res Hepatol Gastroenterol. 2020 Jan 7. pii: S2210-7401(19)30260-8. doi: 10.1016/j.clinre.2019.12.001. [Epub ahead of print]

PMID:
31924555
2.
3.

Association between serum IgG level and clinical course in primary sclerosing cholangitis.

Hippchen T, Sauer P, Göppert B, Schirmacher P, Gotthardt DN, Weiss KH, Stremmel W, Rupp C.

BMC Gastroenterol. 2019 Aug 27;19(1):153. doi: 10.1186/s12876-019-1075-0.

4.

Phosphatidylcholine Passes by Paracellular Transport to the Apical Side of the Polarized Biliary Tumor Cell Line Mz-ChA-1.

Stremmel W, Staffer S, Weiskirchen R.

Int J Mol Sci. 2019 Aug 19;20(16). pii: E4034. doi: 10.3390/ijms20164034.

5.

Hereditary hyperferritinaemia-cataract syndrome (HHCS) - an underestimated condition: ferritin light chain variant spectrum in German families.

Volkmann M, Richter R, Herrmann T, Hentze S, Hör M, Hasche H, Selle B, Stremmel W, Gehrke SG.

Clin Chem Lab Med. 2019 Nov 26;57(12):1837-1845. doi: 10.1515/cclm-2018-1354.

PMID:
31211687
6.

The interesting case-orphan diseases-double trouble.

Reuner U, Stremmel W, Weiskirchen R.

Ann Transl Med. 2019 Apr;7(Suppl 2):S74. doi: 10.21037/atm.2019.04.31.

7.

Clinical features of Wilson disease.

Stremmel W, Merle U, Weiskirchen R.

Ann Transl Med. 2019 Apr;7(Suppl 2):S61. doi: 10.21037/atm.2019.01.20. Review.

8.

Editorial for focused issue "Wilson Disease: From Genetics to Management of Disease".

Weiskirchen R, Stremmel W.

Ann Transl Med. 2019 Apr;7(Suppl 2):S55. doi: 10.21037/atm.2018.12.06. No abstract available.

9.

Hepatic Encephalopathy Aggravated by Systemic Inflammation.

Manzhalii E, Virchenko O, Falalyeyeva T, Moiseienko V, Nykula T, Kondratiuk V, Savchuk O, Beregova T, Stremmel W.

Dig Dis. 2019;37(6):509-517. doi: 10.1159/000500717. Epub 2019 Jun 6.

PMID:
31170723
10.

The Detergent Effect of Mesalazine Interferes with Phosphatidylcholine Binding to Mucin 2.

Stremmel W, Staffer S, Gehrke S.

Inflamm Intest Dis. 2019 Feb;3(3):107-115. doi: 10.1159/000493347. Epub 2018 Oct 18.

11.

An alternative membrane topology permits lipid droplet localization of peroxisomal fatty acyl-CoA reductase 1.

Exner T, Romero-Brey I, Yifrach E, Rivera-Monroy J, Schrul B, Zouboulis CC, Stremmel W, Honsho M, Bartenschlager R, Zalckvar E, Poppelreuther M, Füllekrug J.

J Cell Sci. 2019 Mar 18;132(6). pii: jcs223016. doi: 10.1242/jcs.223016.

12.

Survival of Hepatocellular Carcinoma Patients Treated with Sorafenib beyond Progression.

Apostolidis L, Pfeiffenberger J, Gotthardt D, Radeleff B, Mehrabi A, Schemmer P, Jäger D, Schirmacher P, Stremmel W, Schulze-Bergkamen H, Springfeld C, Weiss KH.

Gastrointest Tumors. 2018 Sep;5(1-2):38-46. doi: 10.1159/000487635. Epub 2018 Apr 11.

13.

Shear-Enhanced Dynamic Adhesion of Lactobacillus rhamnosus GG on Intestinal Epithelia: Correlative Effect of Protein Expression and Interface Mechanics.

Eshrati M, Amadei F, Staffer S, Stremmel W, Tanaka M.

Langmuir. 2019 Jan 15;35(2):529-537. doi: 10.1021/acs.langmuir.8b02931. Epub 2019 Jan 2.

PMID:
30567428
14.

Elevation of blood lipids in hepatocyte-specific fatty acid transport 4-deficient mice fed with high glucose diets.

Döring S, Seeßle J, Gan-Schreier H, Javaheri B, Jiao L, Cheng Y, Tuma-Kellner S, Liebisch G, Herrmann T, Stremmel W, Chamulitrat W.

Mol Genet Metab. 2019 Jan;126(1):30-38. doi: 10.1016/j.ymgme.2018.11.010. Epub 2018 Nov 23.

PMID:
30497809
15.

Nonclassical Interactions of Phosphatidylcholine with Mucin Protect Intestinal Surfaces: A Microinterferometry Study.

Amadei F, Fröhlich B, Stremmel W, Tanaka M.

Langmuir. 2018 Nov 20;34(46):14046-14057. doi: 10.1021/acs.langmuir.8b03035. Epub 2018 Nov 6.

PMID:
30359036
16.

Bivalent Ligand UDCA-LPE Inhibits Pro-Fibrogenic Integrin Signalling by Inducing Lipid Raft-Mediated Internalization.

Su J, Gan-Schreier H, Goeppert B, Chamulitrat W, Stremmel W, Pathil A.

Int J Mol Sci. 2018 Oct 20;19(10). pii: E3254. doi: 10.3390/ijms19103254.

17.

Age and Sex but Not ATP7B Genotype Effectively Influence the Clinical Phenotype of Wilson Disease.

Ferenci P, Stremmel W, Członkowska A, Szalay F, Viveiros A, Stättermayer AF, Bruha R, Houwen R, Pop TL, Stauber R, Gschwantler M, Pfeiffenberger J, Yurdaydin C, Aigner E, Steindl-Munda P, Dienes HP, Zoller H, Weiss KH.

Hepatology. 2019 Apr;69(4):1464-1476. doi: 10.1002/hep.30280. Epub 2019 Mar 1.

PMID:
30232804
18.

Real-World Outcomes of Vedolizumab Therapy in Ulcerative Colitis and Crohn's Disease at a Tertiary Referral Center.

Hoffmann P, Krisam J, Stremmel W, Gauss A.

Dig Dis. 2019;37(1):33-44. doi: 10.1159/000492322. Epub 2018 Aug 22.

PMID:
30134234
19.

Bis-choline Tetrathiomolybdate as Old Drug in a New Design for Wilson's Disease: Good for Brain and Liver?

Stremmel W.

Hepatology. 2019 Feb;69(2):901-903. doi: 10.1002/hep.30130. Epub 2018 Dec 28. No abstract available.

20.

Phospholipase A2 of Microbiota as Pathogenetic Determinant to Induce Inflammatory States in Ulcerative Colitis: Therapeutic Implications of Phospholipase A2 Inhibitors.

Stremmel W, Staffer S, Stuhrmann N, Gan-Schreier H, Gauss A, Burger N, Hornuss D.

Inflamm Intest Dis. 2018 Mar;2(3):180-187. doi: 10.1159/000486858. Epub 2018 Mar 6.

Supplemental Content

Loading ...
Support Center